First off that is chump change in the scheme of things and second they only need to sell 60,000 per quarter anywhere in the world and they breakeven, and third the MoNsTeR can't be stopped!!
10/13/2015 was very relevant, ActiPatch FDA Product Category Reclassified from Class 3, the most strictly regulated, to Class 2. This Reclassification made the 2/3/2017 OTC Clearance possible.
8/8/2002 was relevant, Actiband, the first generation of the ActiPatch, received FDA Clearance for "For the treatment of edema following Blepharoplasty"